Rhythm Pharmaceuticals (RYTM) Stock Chart & Stock Price History $56.04 -0.08 (-0.14%) (As of 05:26 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rhythm Pharmaceuticals Stock Price Performance 5 Day Performance+2.94%1 Month Performance-7.79%3 Month Performance+8.25%6 Month Performance+32.00%Year-To-Date Performance+20.23%1 Year Performance+19.24% Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address No one’s talking about these Trump trades (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today RYTM Stock Chart for Monday, December, 23, 2024 RYTM Chart by TradingView Rhythm Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$55.48$56.12+1.15%$58.16$55.471.52 million shs$3.45 billion12/19/2024$53.69$55.48+3.33%$56.42$53.43586,267 shs$3.41 billion12/18/2024$56.80$53.69-5.48%$57.27$53.39710,769 shs$3.30 billion12/17/2024$55.25$56.80+2.81%$56.87$54.52539,643 shs$3.49 billion12/16/2024$55.24$55.25+0.02%$56.83$54.65462,527 shs$3.40 billion12/13/2024$55.68$55.24-0.79%$57.05$54.93519,522 shs$3.40 billion Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$57.15$55.68-2.57%$58.00$54.96439,999 shs$3.42 billion12/11/2024$57.74$57.15-1.02%$58.56$57.01264,065 shs$3.51 billion12/10/2024$57.41$57.74+0.57%$58.46$56.85522,155 shs$3.55 billion12/09/2024$58.89$57.41-2.51%$59.29$56.43299,788 shs$3.53 billion12/06/2024$57.82$58.89+1.85%$59.35$58.31346,623 shs$3.62 billion12/05/2024$60.37$57.82-4.22%$60.63$57.43373,055 shs$3.55 billion12/04/2024$60.08$60.37+0.48%$60.90$59.67914,301 shs$3.71 billion12/03/2024$60.84$60.08-1.25%$61.61$59.94575,603 shs$3.69 billion12/02/2024$62.04$60.84-1.93%$62.10$60.36465,926 shs$3.74 billion11/29/2024$62.25$62.04-0.34%$62.51$61.37254,211 shs$3.81 billion11/28/2024$62.25$62.25$63.44$61.55432,859 shs$3.83 billion11/27/2024$61.95$62.25+0.48%$63.44$61.55432,859 shs$3.83 billion11/26/2024$59.92$61.95+3.39%$62.75$59.60868,862 shs$3.81 billion11/25/2024$59.94$59.92-0.03%$63.08$59.81682,617 shs$3.68 billion11/22/2024$59.27$59.94+1.13%$60.25$59.00302,442 shs$3.68 billion Related Companies Genmab A/S Stock Chart Dr. Reddy's Laboratories Stock Chart Sarepta Therapeutics Stock Chart Catalent Stock Chart Vaxcyte Stock Chart Qiagen Stock Chart Intra-Cellular Therapies Stock Chart Roivant Sciences Stock Chart Ascendis Pharma A/S Stock Chart Revolution Medicines Stock Chart Receive RYTM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RYTM) was last updated on 12/23/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYTM Stock Alerts